Mirae Asset Global Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Buy |
1,902
+270
| +17% | +$28.2K | ﹤0.01% | 1051 |
|
|
2025
Q1 | $193K | Buy |
1,632
+17
| +1% | +$2.02K | ﹤0.01% | 1053 |
|
|
2024
Q4 | $140K | Sell |
1,615
-121
| -7% | -$10.5K | ﹤0.01% | 1099 |
|
|
2024
Q3 | $156K | Buy |
1,736
+318
| +22% | +$28.5K | ﹤0.01% | 1130 |
|
|
2024
Q2 | $114K | Sell |
1,418
-13,831
| -91% | -$1.11M | ﹤0.01% | 1126 |
|
|
2024
Q1 | $964K | Sell |
15,249
-2,713
| -15% | -$171K | ﹤0.01% | 1561 |
|
|
2023
Q4 | $1.43M | Buy |
17,962
+72
| +0.4% | +$5.73K | ﹤0.01% | 1424 |
|
|
2023
Q3 | $1.25M | Buy |
17,890
+2,645
| +17% | +$185K | ﹤0.01% | 1412 |
|
|
2023
Q2 | $1.1M | Buy |
15,245
+329
| +2% | +$23.6K | ﹤0.01% | 1511 |
|
|
2023
Q1 | $920K | Sell |
14,916
-26
| -0.2% | -$1.6K | ﹤0.01% | 1591 |
|
|
2022
Q4 | $1.15M | Buy |
14,942
+1,794
| +14% | +$138K | ﹤0.01% | 1410 |
|
|
2022
Q3 | $587K | Buy |
+13,148
| New | +$587K | ﹤0.01% | 1779 |
|